12:00 AM
 | 
Mar 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Niox Mino regulatory update

Aerocrine said Texas' Medicaid program will add coverage of fractional exhaled Nitric Oxide (FeNO) testing, effective April 1. Aerocrine's...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >